Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882796-08-000035
Filing Date
2008-08-13
Accepted
2008-08-13 14:26:29
Documents
1
Period of Report
2008-08-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc.html 4  
1 PRIMARY DOCUMENT doc.xml 4 3602
  Complete submission text file 0000882796-08-000035.txt   5398
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 205-444-4600
Stonehouse Jon P (Reporting) CIK: 0001385496 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 081012848